Treatment.com AI Statistics
Total Valuation
Treatment.com AI has a market cap or net worth of 18.11 million. The enterprise value is 16.87 million.
| Market Cap | 18.11M |
| Enterprise Value | 16.87M |
Important Dates
The next estimated earnings date is Thursday, December 5, 2024.
| Earnings Date | Dec 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +437.87% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 44.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.36 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -221.31% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.75% in the last 52 weeks. The beta is -0.45, so Treatment.com AI's price volatility has been lower than the market average.
| Beta (5Y) | -0.45 |
| 52-Week Price Change | -8.75% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 40.67 |
| Average Volume (20 Days) | 6,040 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Treatment.com AI had revenue of 28,191 and -1.49 million in losses. Loss per share was -0.12.
| Revenue | 28,191 |
| Gross Profit | 17,882 |
| Operating Income | -1.43M |
| Pretax Income | -1.49M |
| Net Income | -1.49M |
| EBITDA | n/a |
| EBIT | -1.43M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 663,384 in cash and 450,320 in debt, giving a net cash position of 213,064.
| Cash & Cash Equivalents | 663,384 |
| Total Debt | 450,320 |
| Net Cash | 213,064 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -491,723 |
| Book Value Per Share | -0.01 |
| Working Capital | -491,723 |
Cash Flow
| Operating Cash Flow | -147,821 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 63.43% |
| Operating Margin | -5,080.28% |
| Pretax Margin | -5,268.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Treatment.com AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.95% |
| Shareholder Yield | -78.95% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Treatment.com AI has an Altman Z-Score of -39.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.52 |
| Piotroski F-Score | n/a |